ARCHIVES

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

Scope Of Panel’s Inquiry Outlined In Letter To Members

July 22, 1994

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005